nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—CYP3A4—type 2 diabetes mellitus	0.275	1	CbGaD
Mebendazole—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0638	0.133	CbGbCtD
Mebendazole—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0568	0.118	CbGbCtD
Mebendazole—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0411	0.0854	CbGbCtD
Mebendazole—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0382	0.0794	CbGbCtD
Mebendazole—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0341	0.0708	CbGbCtD
Mebendazole—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0312	0.0648	CbGbCtD
Mebendazole—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0282	0.0587	CbGbCtD
Mebendazole—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0272	0.0566	CbGbCtD
Mebendazole—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0246	0.0512	CbGbCtD
Mebendazole—ABCB1—Glyburide—type 2 diabetes mellitus	0.021	0.0437	CbGbCtD
Mebendazole—ABCB1—Losartan—type 2 diabetes mellitus	0.0192	0.04	CbGbCtD
Mebendazole—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0187	0.0388	CbGbCtD
Mebendazole—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0179	0.0372	CbGbCtD
Mebendazole—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0179	0.0372	CbGbCtD
Mebendazole—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0169	0.0352	CbGbCtD
Mebendazole—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0126	0.0262	CbGbCtD
Mebendazole—CYP3A4—Losartan—type 2 diabetes mellitus	0.0115	0.024	CbGbCtD
Mebendazole—TUBA1A—peripheral nervous system—type 2 diabetes mellitus	0.0072	0.148	CbGeAlD
Mebendazole—TUBA1A—nerve—type 2 diabetes mellitus	0.00561	0.115	CbGeAlD
Mebendazole—TUBA1A—islet of Langerhans—type 2 diabetes mellitus	0.00272	0.0558	CbGeAlD
Mebendazole—Agranulocytosis—Tolbutamide—type 2 diabetes mellitus	0.00243	0.0197	CcSEcCtD
Mebendazole—TUBA1A—retina—type 2 diabetes mellitus	0.00232	0.0477	CbGeAlD
Mebendazole—Agranulocytosis—Chlorpropamide—type 2 diabetes mellitus	0.00221	0.0179	CcSEcCtD
Mebendazole—Agranulocytosis—Tolazamide—type 2 diabetes mellitus	0.00221	0.0179	CcSEcCtD
Mebendazole—TUBA1A—nephron tubule—type 2 diabetes mellitus	0.00219	0.0449	CbGeAlD
Mebendazole—Hepatitis—Acarbose—type 2 diabetes mellitus	0.00205	0.0165	CcSEcCtD
Mebendazole—TUBA1A—cardiovascular system—type 2 diabetes mellitus	0.00197	0.0404	CbGeAlD
Mebendazole—TUBA1A—kidney—type 2 diabetes mellitus	0.00192	0.0395	CbGeAlD
Mebendazole—TUBA1A—pancreas—type 2 diabetes mellitus	0.00191	0.0392	CbGeAlD
Mebendazole—TUBA1A—cortex of kidney—type 2 diabetes mellitus	0.00187	0.0385	CbGeAlD
Mebendazole—TUBB4B—islet of Langerhans—type 2 diabetes mellitus	0.00181	0.0372	CbGeAlD
Mebendazole—TUBA1A—adipose tissue—type 2 diabetes mellitus	0.00173	0.0356	CbGeAlD
Mebendazole—Hepatitis—Repaglinide—type 2 diabetes mellitus	0.00171	0.0138	CcSEcCtD
Mebendazole—Angioedema—Linagliptin—type 2 diabetes mellitus	0.00168	0.0135	CcSEcCtD
Mebendazole—Hepatitis—Rosiglitazone—type 2 diabetes mellitus	0.00161	0.013	CcSEcCtD
Mebendazole—Bopindolol—ADRB3—type 2 diabetes mellitus	0.00157	0.332	CrCbGaD
Mebendazole—TUBB4B—retina—type 2 diabetes mellitus	0.00155	0.0318	CbGeAlD
Mebendazole—Gastrointestinal pain—Miglitol—type 2 diabetes mellitus	0.00151	0.0122	CcSEcCtD
Mebendazole—Agranulocytosis—Glipizide—type 2 diabetes mellitus	0.00147	0.0119	CcSEcCtD
Mebendazole—Abdominal pain—Miglitol—type 2 diabetes mellitus	0.00146	0.0118	CcSEcCtD
Mebendazole—TUBB4B—nephron tubule—type 2 diabetes mellitus	0.00146	0.03	CbGeAlD
Mebendazole—Hepatitis—Glipizide—type 2 diabetes mellitus	0.00141	0.0114	CcSEcCtD
Mebendazole—Agranulocytosis—Glimepiride—type 2 diabetes mellitus	0.00137	0.0111	CcSEcCtD
Mebendazole—Hepatitis—Pioglitazone—type 2 diabetes mellitus	0.00135	0.0109	CcSEcCtD
Mebendazole—Urticaria—Tolbutamide—type 2 diabetes mellitus	0.00132	0.0107	CcSEcCtD
Mebendazole—Hepatitis—Glimepiride—type 2 diabetes mellitus	0.00132	0.0107	CcSEcCtD
Mebendazole—TUBB4B—cardiovascular system—type 2 diabetes mellitus	0.00131	0.0269	CbGeAlD
Mebendazole—Angioedema—Rosiglitazone—type 2 diabetes mellitus	0.00128	0.0104	CcSEcCtD
Mebendazole—TUBB4B—kidney—type 2 diabetes mellitus	0.00128	0.0263	CbGeAlD
Mebendazole—TUBB4B—pancreas—type 2 diabetes mellitus	0.00127	0.0261	CbGeAlD
Mebendazole—TUBB4B—cortex of kidney—type 2 diabetes mellitus	0.00125	0.0256	CbGeAlD
Mebendazole—TUBA1A—liver—type 2 diabetes mellitus	0.00122	0.025	CbGeAlD
Mebendazole—Urticaria—Chlorpropamide—type 2 diabetes mellitus	0.0012	0.00971	CcSEcCtD
Mebendazole—Urticaria—Tolazamide—type 2 diabetes mellitus	0.0012	0.00971	CcSEcCtD
Mebendazole—Urticaria—Linagliptin—type 2 diabetes mellitus	0.00119	0.00961	CcSEcCtD
Mebendazole—Gastrointestinal pain—Acarbose—type 2 diabetes mellitus	0.00119	0.00961	CcSEcCtD
Mebendazole—Rash—Miglitol—type 2 diabetes mellitus	0.00117	0.00942	CcSEcCtD
Mebendazole—Dermatitis—Miglitol—type 2 diabetes mellitus	0.00117	0.00942	CcSEcCtD
Mebendazole—TUBB4B—adipose tissue—type 2 diabetes mellitus	0.00116	0.0237	CbGeAlD
Mebendazole—Urticaria—Acarbose—type 2 diabetes mellitus	0.00116	0.00933	CcSEcCtD
Mebendazole—Abdominal pain—Acarbose—type 2 diabetes mellitus	0.00115	0.00929	CcSEcCtD
Mebendazole—Gastrointestinal pain—Nateglinide—type 2 diabetes mellitus	0.00115	0.00926	CcSEcCtD
Mebendazole—Agranulocytosis—Glyburide—type 2 diabetes mellitus	0.00113	0.00913	CcSEcCtD
Mebendazole—Urticaria—Nateglinide—type 2 diabetes mellitus	0.00111	0.009	CcSEcCtD
Mebendazole—Abdominal pain—Nateglinide—type 2 diabetes mellitus	0.00111	0.00895	CcSEcCtD
Mebendazole—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.0011	0.00892	CcSEcCtD
Mebendazole—Hepatitis—Glyburide—type 2 diabetes mellitus	0.00109	0.00879	CcSEcCtD
Mebendazole—Angioedema—Pioglitazone—type 2 diabetes mellitus	0.00108	0.0087	CcSEcCtD
Mebendazole—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00107	0.00865	CcSEcCtD
Mebendazole—Albendazole—CYP1A2—type 2 diabetes mellitus	0.00106	0.223	CrCbGaD
Mebendazole—Angioedema—Glimepiride—type 2 diabetes mellitus	0.00105	0.00848	CcSEcCtD
Mebendazole—Rash—Tolbutamide—type 2 diabetes mellitus	0.00105	0.00847	CcSEcCtD
Mebendazole—Neutropenia—Valsartan—type 2 diabetes mellitus	0.00105	0.00847	CcSEcCtD
Mebendazole—Angioedema—Sitagliptin—type 2 diabetes mellitus	0.00105	0.00845	CcSEcCtD
Mebendazole—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00103	0.00835	CcSEcCtD
Mebendazole—Agranulocytosis—Gliclazide—type 2 diabetes mellitus	0.00102	0.0082	CcSEcCtD
Mebendazole—Convulsion—Glimepiride—type 2 diabetes mellitus	0.000995	0.00804	CcSEcCtD
Mebendazole—Gastrointestinal pain—Repaglinide—type 2 diabetes mellitus	0.000992	0.00802	CcSEcCtD
Mebendazole—Hepatitis—Gliclazide—type 2 diabetes mellitus	0.000977	0.00789	CcSEcCtD
Mebendazole—Urticaria—Repaglinide—type 2 diabetes mellitus	0.000964	0.00779	CcSEcCtD
Mebendazole—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.000959	0.00775	CcSEcCtD
Mebendazole—Neutropenia—Metformin—type 2 diabetes mellitus	0.000955	0.00771	CcSEcCtD
Mebendazole—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000954	0.00771	CcSEcCtD
Mebendazole—Rash—Tolazamide—type 2 diabetes mellitus	0.000954	0.00771	CcSEcCtD
Mebendazole—Rash—Linagliptin—type 2 diabetes mellitus	0.000945	0.00763	CcSEcCtD
Mebendazole—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000944	0.00762	CcSEcCtD
Mebendazole—Rash—Acarbose—type 2 diabetes mellitus	0.000917	0.00741	CcSEcCtD
Mebendazole—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000916	0.0074	CcSEcCtD
Mebendazole—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.000911	0.00736	CcSEcCtD
Mebendazole—Neutropenia—Irbesartan—type 2 diabetes mellitus	0.000901	0.00728	CcSEcCtD
Mebendazole—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.000897	0.00725	CcSEcCtD
Mebendazole—Hepatitis—Valsartan—type 2 diabetes mellitus	0.000897	0.00725	CcSEcCtD
Mebendazole—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000894	0.00722	CcSEcCtD
Mebendazole—Hepatitis—Orlistat—type 2 diabetes mellitus	0.000887	0.00716	CcSEcCtD
Mebendazole—Rash—Nateglinide—type 2 diabetes mellitus	0.000884	0.00714	CcSEcCtD
Mebendazole—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000883	0.00714	CcSEcCtD
Mebendazole—Angioedema—Glyburide—type 2 diabetes mellitus	0.000865	0.00699	CcSEcCtD
Mebendazole—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000821	0.00663	CcSEcCtD
Mebendazole—Convulsion—Glyburide—type 2 diabetes mellitus	0.00082	0.00663	CcSEcCtD
Mebendazole—Hepatitis—Metformin—type 2 diabetes mellitus	0.000817	0.0066	CcSEcCtD
Mebendazole—TUBB4B—liver—type 2 diabetes mellitus	0.000811	0.0166	CbGeAlD
Mebendazole—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000802	0.00648	CcSEcCtD
Mebendazole—Urticaria—Glipizide—type 2 diabetes mellitus	0.000798	0.00644	CcSEcCtD
Mebendazole—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000794	0.00641	CcSEcCtD
Mebendazole—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000777	0.00628	CcSEcCtD
Mebendazole—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.000771	0.00623	CcSEcCtD
Mebendazole—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000766	0.00619	CcSEcCtD
Mebendazole—Rash—Repaglinide—type 2 diabetes mellitus	0.000765	0.00618	CcSEcCtD
Mebendazole—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000765	0.00618	CcSEcCtD
Mebendazole—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000764	0.00617	CcSEcCtD
Mebendazole—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000764	0.00617	CcSEcCtD
Mebendazole—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000754	0.00609	CcSEcCtD
Mebendazole—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000744	0.00601	CcSEcCtD
Mebendazole—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000742	0.00599	CcSEcCtD
Mebendazole—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000741	0.00598	CcSEcCtD
Mebendazole—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00074	0.00598	CcSEcCtD
Mebendazole—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000738	0.00597	CcSEcCtD
Mebendazole—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000737	0.00595	CcSEcCtD
Mebendazole—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000727	0.00587	CcSEcCtD
Mebendazole—Hepatitis—Losartan—type 2 diabetes mellitus	0.000726	0.00586	CcSEcCtD
Mebendazole—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000723	0.00584	CcSEcCtD
Mebendazole—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000723	0.00584	CcSEcCtD
Mebendazole—CYP1A1—kidney—type 2 diabetes mellitus	0.000718	0.0147	CbGeAlD
Mebendazole—Angioedema—Valsartan—type 2 diabetes mellitus	0.000714	0.00577	CcSEcCtD
Mebendazole—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000709	0.00573	CcSEcCtD
Mebendazole—Angioedema—Orlistat—type 2 diabetes mellitus	0.000705	0.0057	CcSEcCtD
Mebendazole—Albendazole—CYP3A4—type 2 diabetes mellitus	0.0007	0.148	CrCbGaD
Mebendazole—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000691	0.00558	CcSEcCtD
Mebendazole—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00069	0.00558	CcSEcCtD
Mebendazole—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000688	0.00556	CcSEcCtD
Mebendazole—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000672	0.00543	CcSEcCtD
Mebendazole—Convulsion—Orlistat—type 2 diabetes mellitus	0.000669	0.0054	CcSEcCtD
Mebendazole—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000668	0.0054	CcSEcCtD
Mebendazole—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000647	0.0133	CbGeAlD
Mebendazole—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000647	0.00523	CcSEcCtD
Mebendazole—Rash—Glipizide—type 2 diabetes mellitus	0.000633	0.00511	CcSEcCtD
Mebendazole—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000633	0.00511	CcSEcCtD
Mebendazole—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000632	0.0051	CcSEcCtD
Mebendazole—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000622	0.00503	CcSEcCtD
Mebendazole—Urticaria—Glyburide—type 2 diabetes mellitus	0.000614	0.00496	CcSEcCtD
Mebendazole—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000613	0.00496	CcSEcCtD
Mebendazole—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000611	0.00494	CcSEcCtD
Mebendazole—Rash—Glimepiride—type 2 diabetes mellitus	0.000591	0.00477	CcSEcCtD
Mebendazole—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00059	0.00477	CcSEcCtD
Mebendazole—Rash—Sitagliptin—type 2 diabetes mellitus	0.000589	0.00476	CcSEcCtD
Mebendazole—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000588	0.00475	CcSEcCtD
Mebendazole—Angioedema—Losartan—type 2 diabetes mellitus	0.000577	0.00466	CcSEcCtD
Mebendazole—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000569	0.0046	CcSEcCtD
Mebendazole—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000567	0.00458	CcSEcCtD
Mebendazole—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000551	0.00445	CcSEcCtD
Mebendazole—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000549	0.00443	CcSEcCtD
Mebendazole—Rash—Bromocriptine—type 2 diabetes mellitus	0.000533	0.00431	CcSEcCtD
Mebendazole—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000533	0.0043	CcSEcCtD
Mebendazole—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000527	0.0108	CbGeAlD
Mebendazole—CYP3A4—kidney—type 2 diabetes mellitus	0.000527	0.0108	CbGeAlD
Mebendazole—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000521	0.00421	CcSEcCtD
Mebendazole—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000515	0.00416	CcSEcCtD
Mebendazole—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000511	0.00413	CcSEcCtD
Mebendazole—Urticaria—Valsartan—type 2 diabetes mellitus	0.000506	0.00409	CcSEcCtD
Mebendazole—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000504	0.00407	CcSEcCtD
Mebendazole—Urticaria—Orlistat—type 2 diabetes mellitus	0.0005	0.00404	CcSEcCtD
Mebendazole—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000498	0.00402	CcSEcCtD
Mebendazole—Angioedema—Ramipril—type 2 diabetes mellitus	0.000495	0.004	CcSEcCtD
Mebendazole—Rash—Glyburide—type 2 diabetes mellitus	0.000487	0.00394	CcSEcCtD
Mebendazole—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000487	0.00393	CcSEcCtD
Mebendazole—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000475	0.00384	CcSEcCtD
Mebendazole—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00047	0.00379	CcSEcCtD
Mebendazole—Convulsion—Ramipril—type 2 diabetes mellitus	0.000469	0.00379	CcSEcCtD
Mebendazole—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000464	0.00375	CcSEcCtD
Mebendazole—Urticaria—Metformin—type 2 diabetes mellitus	0.000461	0.00373	CcSEcCtD
Mebendazole—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000459	0.00371	CcSEcCtD
Mebendazole—CYP1A1—liver—type 2 diabetes mellitus	0.000454	0.00932	CbGeAlD
Mebendazole—ABCB1—retina—type 2 diabetes mellitus	0.000451	0.00925	CbGeAlD
Mebendazole—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000448	0.00362	CcSEcCtD
Mebendazole—Ketorolac—PTGS2—type 2 diabetes mellitus	0.000441	0.0932	CrCbGaD
Mebendazole—Rash—Gliclazide—type 2 diabetes mellitus	0.000438	0.00353	CcSEcCtD
Mebendazole—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000437	0.00353	CcSEcCtD
Mebendazole—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000435	0.00352	CcSEcCtD
Mebendazole—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000433	0.0035	CcSEcCtD
Mebendazole—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000424	0.00871	CbGeAlD
Mebendazole—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000422	0.00341	CcSEcCtD
Mebendazole—Urticaria—Losartan—type 2 diabetes mellitus	0.00041	0.00331	CcSEcCtD
Mebendazole—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000408	0.00329	CcSEcCtD
Mebendazole—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000404	0.00326	CcSEcCtD
Mebendazole—Rash—Valsartan—type 2 diabetes mellitus	0.000402	0.00325	CcSEcCtD
Mebendazole—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000402	0.00324	CcSEcCtD
Mebendazole—Rash—Orlistat—type 2 diabetes mellitus	0.000397	0.00321	CcSEcCtD
Mebendazole—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000397	0.00321	CcSEcCtD
Mebendazole—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000381	0.00782	CbGeAlD
Mebendazole—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00038	0.00307	CcSEcCtD
Mebendazole—ABCB1—kidney—type 2 diabetes mellitus	0.000373	0.00766	CbGeAlD
Mebendazole—ABCB1—pancreas—type 2 diabetes mellitus	0.00037	0.00761	CbGeAlD
Mebendazole—Rash—Metformin—type 2 diabetes mellitus	0.000366	0.00296	CcSEcCtD
Mebendazole—Dermatitis—Metformin—type 2 diabetes mellitus	0.000366	0.00295	CcSEcCtD
Mebendazole—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000363	0.00746	CbGeAlD
Mebendazole—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000362	0.00292	CcSEcCtD
Mebendazole—Tiaprofenic acid—PTGS2—type 2 diabetes mellitus	0.00036	0.076	CrCbGaD
Mebendazole—Urticaria—Ramipril—type 2 diabetes mellitus	0.000351	0.00284	CcSEcCtD
Mebendazole—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00035	0.00282	CcSEcCtD
Mebendazole—Rash—Irbesartan—type 2 diabetes mellitus	0.000345	0.00279	CcSEcCtD
Mebendazole—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000345	0.00279	CcSEcCtD
Mebendazole—Nepafenac—PTGS2—type 2 diabetes mellitus	0.000342	0.0723	CrCbGaD
Mebendazole—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000336	0.0069	CbGeAlD
Mebendazole—CYP3A4—liver—type 2 diabetes mellitus	0.000333	0.00684	CbGeAlD
Mebendazole—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000326	0.00263	CcSEcCtD
Mebendazole—Rash—Losartan—type 2 diabetes mellitus	0.000325	0.00263	CcSEcCtD
Mebendazole—Dermatitis—Losartan—type 2 diabetes mellitus	0.000325	0.00262	CcSEcCtD
Mebendazole—Rash—Ramipril—type 2 diabetes mellitus	0.000279	0.00225	CcSEcCtD
Mebendazole—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000279	0.00225	CcSEcCtD
Mebendazole—ABCB1—liver—type 2 diabetes mellitus	0.000236	0.00484	CbGeAlD
Mebendazole—Ketoprofen—PTGS2—type 2 diabetes mellitus	0.000139	0.0293	CrCbGaD
Mebendazole—Ketoprofen—ALB—type 2 diabetes mellitus	0.000124	0.0261	CrCbGaD
Mebendazole—CYP1A1—Metabolism—CBS—type 2 diabetes mellitus	2.4e-05	0.000361	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	2.39e-05	0.00036	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	2.35e-05	0.000354	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	2.35e-05	0.000354	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.35e-05	0.000354	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	2.35e-05	0.000354	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	2.35e-05	0.000354	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—COX2—type 2 diabetes mellitus	2.31e-05	0.000348	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLC5A2—type 2 diabetes mellitus	2.31e-05	0.000348	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	2.28e-05	0.000343	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NCOA6—type 2 diabetes mellitus	2.27e-05	0.000342	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	2.27e-05	0.000342	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.27e-05	0.000342	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—UCP3—type 2 diabetes mellitus	2.23e-05	0.000336	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HSD11B1—type 2 diabetes mellitus	2.23e-05	0.000336	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—UCP2—type 2 diabetes mellitus	2.23e-05	0.000336	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	2.19e-05	0.000329	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.16e-05	0.000326	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	2.15e-05	0.000324	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	2.15e-05	0.000324	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	2.11e-05	0.000317	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PCK1—type 2 diabetes mellitus	2.1e-05	0.000316	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	2.1e-05	0.000316	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2.09e-05	0.000314	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.07e-05	0.000311	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	2.06e-05	0.00031	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.02e-05	0.000303	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	2e-05	0.000301	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	2e-05	0.000301	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	2e-05	0.000301	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	2e-05	0.000301	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	1.97e-05	0.000296	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HK1—type 2 diabetes mellitus	1.97e-05	0.000296	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.96e-05	0.000295	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	1.92e-05	0.000289	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	1.92e-05	0.000289	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—LPA—type 2 diabetes mellitus	1.9e-05	0.000286	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.9e-05	0.000286	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GCKR—type 2 diabetes mellitus	1.9e-05	0.000286	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.9e-05	0.000286	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	1.85e-05	0.000278	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	1.85e-05	0.000278	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.84e-05	0.000276	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.83e-05	0.000275	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ALDOB—type 2 diabetes mellitus	1.82e-05	0.000274	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	1.81e-05	0.000273	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.8e-05	0.000271	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.8e-05	0.000271	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	1.79e-05	0.000269	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	1.78e-05	0.000268	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	1.78e-05	0.000268	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	1.78e-05	0.000268	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.77e-05	0.000266	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.73e-05	0.000261	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.72e-05	0.000259	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.72e-05	0.000258	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.71e-05	0.000258	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.71e-05	0.000257	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.71e-05	0.000257	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.7e-05	0.000256	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GLP1R—type 2 diabetes mellitus	1.69e-05	0.000255	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	1.68e-05	0.000252	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.64e-05	0.000247	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.64e-05	0.000247	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.63e-05	0.000245	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.61e-05	0.000242	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.58e-05	0.000238	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	1.57e-05	0.000236	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MTR—type 2 diabetes mellitus	1.55e-05	0.000233	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CPT1A—type 2 diabetes mellitus	1.55e-05	0.000233	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.54e-05	0.000231	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.53e-05	0.000231	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NAMPT—type 2 diabetes mellitus	1.52e-05	0.000228	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.52e-05	0.000228	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.52e-05	0.000228	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.52e-05	0.000228	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.52e-05	0.000228	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.51e-05	0.000227	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—LIPC—type 2 diabetes mellitus	1.51e-05	0.000227	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HBA1—type 2 diabetes mellitus	1.51e-05	0.000227	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GCK—type 2 diabetes mellitus	1.51e-05	0.000227	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.5e-05	0.000226	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.5e-05	0.000226	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.5e-05	0.000226	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.47e-05	0.000221	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CETP—type 2 diabetes mellitus	1.46e-05	0.000219	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.45e-05	0.000219	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.45e-05	0.000218	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.45e-05	0.000218	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.45e-05	0.000218	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.45e-05	0.000218	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.45e-05	0.000218	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.4e-05	0.000211	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.39e-05	0.000209	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.36e-05	0.000204	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SNAP25—type 2 diabetes mellitus	1.35e-05	0.000204	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PSMD6—type 2 diabetes mellitus	1.35e-05	0.000204	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SREBF1—type 2 diabetes mellitus	1.35e-05	0.000204	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	1.35e-05	0.000203	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CTGF—type 2 diabetes mellitus	1.33e-05	0.0002	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.33e-05	0.0002	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.33e-05	0.0002	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HMGCR—type 2 diabetes mellitus	1.32e-05	0.000198	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.3e-05	0.000196	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.3e-05	0.000195	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.29e-05	0.000194	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.29e-05	0.000194	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.26e-05	0.00019	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.24e-05	0.000186	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	1.24e-05	0.000186	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	1.24e-05	0.000186	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.23e-05	0.000185	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.23e-05	0.000185	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.23e-05	0.000185	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.22e-05	0.000184	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.22e-05	0.000184	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	1.21e-05	0.000182	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	1.2e-05	0.000181	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	1.2e-05	0.000181	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	1.2e-05	0.000181	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.2e-05	0.00018	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.19e-05	0.000179	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.19e-05	0.000179	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.18e-05	0.000178	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.18e-05	0.000178	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.18e-05	0.000177	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.17e-05	0.000176	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GCG—type 2 diabetes mellitus	1.17e-05	0.000176	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	1.16e-05	0.000175	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.14e-05	0.000172	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.14e-05	0.000171	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.14e-05	0.000171	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.12e-05	0.000168	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.1e-05	0.000165	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.1e-05	0.000165	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.1e-05	0.000165	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	1.08e-05	0.000163	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	1.08e-05	0.000163	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	1.08e-05	0.000163	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	1.06e-05	0.00016	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	1.05e-05	0.000158	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.03e-05	0.000155	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.03e-05	0.000155	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.03e-05	0.000155	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.01e-05	0.000152	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GNB3—type 2 diabetes mellitus	1.01e-05	0.000152	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HMOX1—type 2 diabetes mellitus	1.01e-05	0.000151	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CAT—type 2 diabetes mellitus	9.93e-06	0.000149	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	9.88e-06	0.000149	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	9.77e-06	0.000147	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	9.77e-06	0.000147	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	9.68e-06	0.000146	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—APOB—type 2 diabetes mellitus	9.64e-06	0.000145	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	9.53e-06	0.000143	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTM1—type 2 diabetes mellitus	9.38e-06	0.000141	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	9.37e-06	0.000141	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	9.37e-06	0.000141	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	9.34e-06	0.000141	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	9.34e-06	0.000141	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	9.34e-06	0.000141	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	9.34e-06	0.000141	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	9.21e-06	0.000138	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	9.01e-06	0.000136	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	8.98e-06	0.000135	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	8.96e-06	0.000135	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	8.75e-06	0.000132	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	8.64e-06	0.00013	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	8.33e-06	0.000125	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	8.29e-06	0.000125	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	8.13e-06	0.000122	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	8.08e-06	0.000121	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.08e-06	0.000121	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	8.04e-06	0.000121	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	7.93e-06	0.000119	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	7.88e-06	0.000118	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	7.78e-06	0.000117	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	7.74e-06	0.000116	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	7.72e-06	0.000116	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	7.7e-06	0.000116	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	7.63e-06	0.000115	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	7.62e-06	0.000115	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	7.62e-06	0.000115	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	7.49e-06	0.000113	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	7.47e-06	0.000112	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	7.42e-06	0.000112	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	7.42e-06	0.000112	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	7.42e-06	0.000112	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	7.38e-06	0.000111	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	7.35e-06	0.000111	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	7.25e-06	0.000109	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	7.2e-06	0.000108	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	7.17e-06	0.000108	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	7.16e-06	0.000108	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	6.99e-06	0.000105	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.9e-06	0.000104	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	6.72e-06	0.000101	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6.66e-06	0.0001	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6.66e-06	0.0001	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6.66e-06	0.0001	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	6.62e-06	9.96e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	6.59e-06	9.92e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	6.54e-06	9.83e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	6.49e-06	9.77e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	6.48e-06	9.74e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	6.34e-06	9.53e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	6.29e-06	9.46e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	6.19e-06	9.3e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	6.16e-06	9.27e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	6.09e-06	9.16e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	6.09e-06	9.16e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	6.04e-06	9.09e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	6.02e-06	9.06e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	6.02e-06	9.06e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.78e-06	8.7e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	5.78e-06	8.7e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.77e-06	8.68e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.77e-06	8.68e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	5.37e-06	8.08e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	5.29e-06	7.95e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—INS—type 2 diabetes mellitus	5.27e-06	7.92e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.98e-06	7.48e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.98e-06	7.48e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.95e-06	7.45e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.89e-06	7.35e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	4.83e-06	7.26e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.74e-06	7.14e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.62e-06	6.95e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	4.62e-06	6.95e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.62e-06	6.94e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.53e-06	6.81e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.43e-06	6.67e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.42e-06	6.65e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.3e-06	6.47e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.25e-06	6.39e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	4.22e-06	6.35e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.08e-06	6.14e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4e-06	6.02e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.88e-06	5.83e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.81e-06	5.73e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.8e-06	5.71e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.75e-06	5.65e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.31e-06	4.98e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.24e-06	4.88e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.97e-06	4.47e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.84e-06	4.28e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.84e-06	4.28e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	2.66e-06	4e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.6e-06	3.91e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.12e-06	3.19e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.31e-06	1.97e-05	CbGpPWpGaD
